Spots Global Cancer Trial Database for Effect of Rifampicin on the Pharmacokinetics of Apatinib
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Effect of Rifampicin on the Pharmacokinetics of Apatinib
Official Title: Effect of Rifampicin on the Pharmacokinetics of Apatinib in Chinese Healthy Volunteers
Study ID: NCT02836821
Conditions
Study Description
Brief Summary: The primary purpose of this study is to investigate potential pharmacokinetic interaction in healthy volunteers when apatinib is administered in combination with rifampicin. Secondary objective is evaluating the safety and tolerability of apatinib alone and when co-administered with rifampicin.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT
Sex: ALL
Healthy Volunteers: Yes
Locations
Shanghai Xuhui Central Hospital, Shanghai, Shanghai, China
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
